Financial News
All News about Novamind Inc
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/bz_lab2.png)
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
Via Benzinga
Topics
Death
Exposures
Death
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/myriam-zilles-kltolk6mk-g-unsplash_0.jpg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/20311.png?v=2)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/bz_addiction.png?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/20311.png?v=2)
Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6
December 02, 2021
From Novamind Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/20311.png?v=2)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/20311.png?v=2)
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
November 29, 2021
From Novamind Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/20311.png?v=2)
Novamind Unveils New Logo and Invests in Unified Brand
November 24, 2021
From Novamind Inc
Via AccessWire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/marcelo-leal-6pcgtjduf6m-unsplash.jpg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/23305.png?v=0)
Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona
November 16, 2021
From Novamind Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/20311.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/23305.png?v=0)
Novamind Enters New Lease Agreement Responding to Patient Demand
November 12, 2021
From Novamind Inc.
Via AccessWire
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_loo.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/23305.png?v=0)
Novamind Secures Insurance Coverage for Ketamine from Four Major Payors
November 10, 2021
From Novamind Inc.
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/23305.png?v=0)
From Novamind Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/23305.png?v=0)
Novamind Reports FY2021 Financial Results and Operating Highlights
November 05, 2021
From Novamind Inc.
Via AccessWire
Exposures
COVID-19
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_djj.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/23305.png?v=0)
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
November 04, 2021
From Novamind Inc.
Via AccessWire
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_psc_637705440531410809.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/20311.png?v=0)
Novamind Unveils Stealth Mode Investment in Alto Neuroscience
October 22, 2021
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/23305.png?v=0)
Novamind Granted DEA Licenses for Psilocybin Research
October 13, 2021
From Novamind Inc.
Via AccessWire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_5.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_6.jpg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/23305.png?v=0)
Novamind to Present at LD Micro and KCSA Conferences
October 08, 2021
From Novamind Inc.
Via AccessWire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pexels-anna-nekrashevich-6801874_4.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/national-cancer-institute-bxxgtqew1m4-unsplash.jpg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/23305.png?v=0)
Novamind Launches New Psychedelic Palliative Care Program
October 07, 2021
From Novamind Inc.
Via AccessWire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_4.jpg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/20311.png?v=0)
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.